Search | Contact Us | Site Map
About UsNews and EventsProducts in DevelopmentSciencePatient Center


Oct 12, 2004
Positive Phase III Trial Results for Rotigotine Patch, Neupro™, in Advanced Parkinson's Disease
Sep 29, 2004
Schwarz Pharma Submits NDA and MAA Applications for Rotigotine Patch Called Neupro™ for the Treatment of Early Parkinson’s Disease
more »

Rotigotine CDS Phase III trials underway for Parkinson's disease.
more »
Rotigotine named to "100 Great Investigational Drugs" List

more »

© 2001 - 2004 ADERIS Pharmaceuticals, Inc.    Trademarks and Terms of Use

Created by PixelMEDIA, Inc. © 2003
Aderis Pharmaceuticals

At Aderis Pharmaceuticals, we're passionate about improving people's lives. Our selectively-acting therapeutics— with increased potency and fewer side-effects— have the potential to make a significant difference for people living with cardiovascular, renal and neurological diseases. Each of our product candidates is a tribute to our people, our partners and our patient-centered approach.